Overcoming inefficiencies to improve access to cell and gene therapy
Drug Discovery World
MARCH 13, 2023
Between the 24 therapies already approved by the FDA 1 and a marked increase in clinical trials, widespread accessibility to precision medicine feels within reach. Before 2019, CGT drug developers still had a young, academic mindset, ordering reagents, materials, and equipment haphazardly and assuming they would show up when needed.
52 
Let's personalize your content